A phase II trial of neoadjuvant gemcitabine, cisplatin plus tislelizumab followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Clinical efficacy, safety and the biomarker analysis

被引：0
|
作者：
Li, Xiao-Yun
Xie, Si-Yi
Chen, Qiu-Yan
Mai, Hai-Qiang
Tang, Lin-Quan
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4025
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy plus tislelizumab followed by concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial.
    Chen, Qiu-Yan
    Mai, Hai-Qiang
    Tang, Lin-Quan
    Luo, Meijuan
    Zhao, Chong
    Mo, Hao-Yuan
    Sun, Rui
    Luo, Dong-Hua
    Wang, Lin
    Guo, Shan-Shan
    Xie, Siyi
    Li, Su-Chen
    Liu, Sai-Lan
    Li, Xiao Yun
    Peng, Jing-Yun
    Qiu, Hui-Zhi
    Sun, Xue-Song
    Liu, LiTing
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Jin, Ting
    Chen, Xiao-Zhong
    Liu, Jian-Jiang
    ONCOLOGY LETTERS, 2015, 10 (02) : 1123 - 1130
  • [3] Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma
    Wang, Fangzheng
    Jiang, Chuner
    Ye, Zhimin
    Sun, Quanquan
    Liu, Tongxin
    Xu, Min
    Wu, Peng
    Shi, Kaiyuan
    Long, Bin
    Rihito, Aizawa
    Masoto, Sakamoto
    Fu, Zhenfu
    ONCOTARGET, 2017, 8 (43) : 75544 - 75556
  • [4] Neoadjuvant Chemotherapy plus Tislelizumab Followed by Adjuvant Tislelizumab for Locoregionally Advanced Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial
    Shiran, S.
    Huang, X.
    Wang, K.
    Wu, R.
    Wang, J.
    Zhang, Y.
    Qu, Y.
    Chen, X.
    Zhang, J.
    Luo, J.
    Yi, J.
    Zhou, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E791 - E791
  • [5] The safety and efficacy of gemcitabine and cisplatin (GP)‐based induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta‐analysis
    Min Tang
    Zhongxiong Jia
    Ju Zhang
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 1561 - 1572
  • [6] Randomized Phase II Trial of Gemcitabine and Cisplatin (GP) versus Docetaxel and Cisplatin (TP) as Induction Chemotherapy followed by Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
    Zang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S106 - S106
  • [7] The safety and efficacy of gemcitabine and cisplatin (GP)-based induction chemotherapy plus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a meta-analysis
    Tang, Min
    Jia, Zhongxiong
    Zhang, Ju
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (03) : 1561 - 1572
  • [8] Durable response of tislelizumab plus cisplatin, nab-paclitaxel followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: A case report
    Tang, Haifeng
    Yang, Donghong
    Luo, Guoqing
    He, Jiaqi
    Yi, Guihua
    Chen, Zihong
    Li, Haiwen
    Luo, Qianbing
    Huang, Ningxin
    Luo, Haiqing
    MEDICINE, 2023, 102 (07) : E32924
  • [9] Safety and efficacy of docetaxel combined with cisplatin as induction chemotherapy followed by cisplatin concurrent chemoradiotherapy plus gemcitabine as adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A prospective and multicenter phase II trial.
    Wang, Zhi Hui
    Peng, Peijian
    Wang, Siyang
    Liu, Yumeng
    Lin, Zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Gemcitabine and cisplatin chemotherapy plus penpulimab combined with or without anlotinib as neoadjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: A prospective, phase II clinical trial
    Mai, Hai-Qiang
    Sun, Xue-Song
    Liu, Li-Ting
    Guo, Shan-Shan
    Liu, Sai Lan
    Li, Xiao-Yun
    Li, Yi-Fu
    Wen, Dongxiang
    Long, Hao-Xiang
    Chen, Qiu-Yan
    Tang, Lin-Quan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345